If future studies confirm an association of TRPC6, TTC28 and ODF3 expression levels with the clinical features and treatment response of meningiomas, monitoring the expression levels of these genes may help predict treatment responses to dexamethasone or levonorgestrel, thereby guiding the development of personalized treatment regimens. Here, TTC28 is linked to meningioma.